FAKTOR OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 06:03:47 2024-06-26 EDT | ||
| 0.48 EUR | -2.04% |
|
| Current month | -16.95% | ||
| 1 month | -15.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 0.48 | -2.04% |
| 24-06-25 | 0.49 | -7.55% |
| 24-06-24 | 0.53 | -7.02% |
| 24-06-21 | 0.57 | 0.00% |
| 24-06-20 | 0.57 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 06:03 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK0P16 |
| ISIN | DE000UK0P167 |
| Date issued | 2022-04-12 |
| Strike | 399.1 $ |
| Maturity | Unlimited |
| Parity | 148.24 : 1 |
| Emission price | 4.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.24 € |
|---|---|
| Lowest since issue | 0.43 € |
| Spread | 0.04 € |
| Spread % | 7.69% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
